Jiao Liu
Impact in
-
- Cancer, Lipids, and Metabolism
- Cancer-related molecular mechanisms research
-
- Ferroptosis and cancer prognosis
Papers in
-
- Inflammasome and immune disorders 4
- RNA modifications and cancer 3
-
- Immune cells in cancer 2
- Immune Response and Inflammation 2
- Co-authors
- Daolin Tang (17 shared papers)Rui Kang (15 shared papers)Runliu Wu (5 shared papers)Chunhua Yu (5 shared papers)J. Li (1 shared paper)Zhuan Zhou (1 shared paper)Xin Chen (1 shared paper)Brent R. Stockwell (1 shared paper)
- Journals
- Science Translational Medicine (3 papers)Trends in Immunology (1 paper)Carcinogenesis (1 paper)Nature Communications (1 paper)Molecular Cell (1 paper)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Jiao Liu
17 papers receiving 461 citations
Jiao Liu's Hit Papers
Peers
Comparison fields: 5 of 60
- Cancer Research 110
- Pulmonary and Respiratory Medicine 214
- Immunology 76
- Molecular Biology 179
- Biological Psychiatry 5
Countries citing papers authored by Jiao Liu
This map shows the geographic impact of Jiao Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiao Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiao Liu more than expected).
Fields of papers citing papers by Jiao Liu
This network shows the impact of papers produced by Jiao Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiao Liu. The network helps show where Jiao Liu may publish in the future.
Co-authors
The 25 scholars most cited alongside Jiao Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Tumor-specific GPX4 degradation enhances ferroptosis-initiated antitumor immune response in mouse models of pancreatic cancer Hit paper breakdown → | 2023 | 192 |
| 2 | Targeting GPX4 in ferroptosis and cancer: chemical strategies and challenges Hit paper breakdown → | 2024 | 64 |
| 3 | 2022 | 52 | |
| 4 | 2024 | 50 | |
| 5 | 2024 | 21 | |
| 6 | 2023 | 17 | |
| 7 | 2025 | 16 | |
| 8 | 2024 | 8 | |
| 9 | 2025 | 8 | |
| 10 | 2025 | 8 | |
| 11 | 2024 | 6 | |
| 12 | 2025 | 5 | |
| 13 | 2025 | 5 | |
| 14 | 2025 | 4 | |
| 15 | 2024 | 2 | |
| 16 | 2025 | 2 | |
| 17 | 2024 | 1 | |
| 18 | 2025 | 0 |
About Jiao Liu
Jiao Liu is a scholar working on Molecular Biology, Immunology, Pulmonary and Respiratory Medicine, Oncology and Epidemiology, having authored 18 papers that have together received 461 indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (4 papers), Inflammasome and immune disorders (4 papers), Autophagy in Disease and Therapy (3 papers), RNA modifications and cancer (3 papers), Endoplasmic Reticulum Stress and Disease (2 papers), Cancer, Lipids, and Metabolism (2 papers), Immune cells in cancer (2 papers) and Immune Response and Inflammation (2 papers). The work is most often cited by research in Cancer Research (110 citations), Pulmonary and Respiratory Medicine (214 citations), Immunology (76 citations), Molecular Biology (179 citations) and Biological Psychiatry (5 citations). Jiao Liu has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Daolin Tang, Rui Kang, Runliu Wu, Chunhua Yu, J. Li, Zhuan Zhou, Xin Chen, Brent R. Stockwell, Guido Kroemer and Fangquan Chen. Their work appears in journals such as Science Translational Medicine, Trends in Immunology, Carcinogenesis, Nature Communications and Molecular Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.